Single Use Support is a pioneering biopharma startup based in Austria, founded in 2016, with a focus on providing innovative fluid and cold chain management solutions for biopharmaceutical manufacturers and Contract Development and Manufacturing Organizations (CDMOs). The company's mission revolves around improving patient safety by enabling the safe and efficient transport and manufacturing of life-saving liquid pharmaceuticals and drug substances globally. Specifically, they offer expertise and solutions tailored to advanced cell and gene therapies, commercial bulk drug substance handling, vaccine manufacturing transfers, and drug productions. Their product range includes a variety of single-use bioprocess containers, assemblies, protective shells, freeze-thaw platforms, fill-drain platforms, 3D bag totes, ultra-cold storage, and transport containers. Their latest investment on 14 January 2021 was in the secondary market, with Pall being the investor. Single Use Support's innovative approach to fluid management and cold chain logistics in the pharmaceutical industry presents a promising opportunity for investors looking to support essential processes in biomanufacturing and contribute to the advancement of life-saving healthcare solutions.
No recent news or press coverage available for Single Use Support.